Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805516670> ?p ?o ?g. }
- W2805516670 abstract "Primary malignant melanoma of the vagina is extremely rare, with a poorer prognosis than cutaneous malignant melanoma. Previous studies have explored the repurposing of itraconazole, a common oral anti-fungal agent, for the treatment of various cancers. Here, we describe a patient with metastatic, unresectable vaginal malignant melanoma treated with 200 mg oral itraconazole twice a day in a clinical window-of-opportunity trial.A 64-year-old Japanese woman with vaginal and inguinal tumours was referred to our institution. On the basis of an initial diagnosis of vaginal cancer metastatic to the inguinal lymph nodes, we treated her with itraconazole in a clinical trial until the biopsy and imaging study results were obtained. During this period, biopsies were performed three times, and 18F-fluoro-deoxyglucose positron emission tomography (FDG/PET)-computed tomography (CT) was performed twice. Biopsy results confirmed the diagnosis of primary malignant melanoma of the vagina. Imaging studies revealed metastases to multiple sites, including the brain, for which she underwent gamma-knife radiosurgery. During the window period before nivolumab initiation, the patient received itraconazole for 30 days. Within a week of itraconazole initiation, pain in the inguinal nodes was ameliorated. PET-CT on days 6 and 30 showed a reduction in tumour size and FDG uptake, respectively. The biopsied specimens obtained on days 1, 13, and 30 were subjected to cDNA microarray analysis, which revealed a 100-fold downregulation in the transcription of four genes: STATH, EEF1A2, TTR, and CDH2. After 12 weeks of nivolumab administration, she developed progressive disease and grade 3 immune-related hepatitis. Discontinuation of nivolumab resulted in the occurrence of left pelvic and inguinal pain. Following re-challenge with itraconazole, the patient has not reported any pain for 4 months.The findings of this case suggest that itraconazole is a potential effective treatment option for primary malignant melanoma of the vagina. Moreover, we identified potential itraconazole target genes, which could help elucidate the mechanism underlying this disease and potentially aid in the development of new therapeutic agents." @default.
- W2805516670 created "2018-06-13" @default.
- W2805516670 creator A5003149433 @default.
- W2805516670 creator A5048632170 @default.
- W2805516670 creator A5058126361 @default.
- W2805516670 creator A5067580254 @default.
- W2805516670 creator A5084957996 @default.
- W2805516670 date "2018-06-04" @default.
- W2805516670 modified "2023-10-18" @default.
- W2805516670 title "Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report" @default.
- W2805516670 cites W1916387106 @default.
- W2805516670 cites W1954172897 @default.
- W2805516670 cites W1970304552 @default.
- W2805516670 cites W1974339734 @default.
- W2805516670 cites W1991248698 @default.
- W2805516670 cites W2009368567 @default.
- W2805516670 cites W2017779999 @default.
- W2805516670 cites W2019607817 @default.
- W2805516670 cites W2029745149 @default.
- W2805516670 cites W2056003066 @default.
- W2805516670 cites W2077152717 @default.
- W2805516670 cites W2088783764 @default.
- W2805516670 cites W2093556618 @default.
- W2805516670 cites W2098455424 @default.
- W2805516670 cites W2109517646 @default.
- W2805516670 cites W2135960556 @default.
- W2805516670 cites W2136515118 @default.
- W2805516670 cites W2138305199 @default.
- W2805516670 cites W2156034369 @default.
- W2805516670 cites W2172155744 @default.
- W2805516670 cites W2407443662 @default.
- W2805516670 cites W2419270646 @default.
- W2805516670 cites W2553340100 @default.
- W2805516670 cites W2553764071 @default.
- W2805516670 cites W2563690360 @default.
- W2805516670 cites W2588626254 @default.
- W2805516670 cites W2591567335 @default.
- W2805516670 cites W2622188990 @default.
- W2805516670 cites W2747703315 @default.
- W2805516670 cites W2760246662 @default.
- W2805516670 cites W2792555078 @default.
- W2805516670 cites W2982938279 @default.
- W2805516670 cites W43741778 @default.
- W2805516670 cites W969758129 @default.
- W2805516670 doi "https://doi.org/10.1186/s12885-018-4520-5" @default.
- W2805516670 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5987480" @default.
- W2805516670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29866134" @default.
- W2805516670 hasPublicationYear "2018" @default.
- W2805516670 type Work @default.
- W2805516670 sameAs 2805516670 @default.
- W2805516670 citedByCount "8" @default.
- W2805516670 countsByYear W28055166702018 @default.
- W2805516670 countsByYear W28055166702019 @default.
- W2805516670 countsByYear W28055166702020 @default.
- W2805516670 countsByYear W28055166702021 @default.
- W2805516670 countsByYear W28055166702022 @default.
- W2805516670 crossrefType "journal-article" @default.
- W2805516670 hasAuthorship W2805516670A5003149433 @default.
- W2805516670 hasAuthorship W2805516670A5048632170 @default.
- W2805516670 hasAuthorship W2805516670A5058126361 @default.
- W2805516670 hasAuthorship W2805516670A5067580254 @default.
- W2805516670 hasAuthorship W2805516670A5084957996 @default.
- W2805516670 hasBestOaLocation W28055166701 @default.
- W2805516670 hasConcept C121608353 @default.
- W2805516670 hasConcept C126322002 @default.
- W2805516670 hasConcept C126838900 @default.
- W2805516670 hasConcept C141071460 @default.
- W2805516670 hasConcept C142724271 @default.
- W2805516670 hasConcept C16005928 @default.
- W2805516670 hasConcept C2775842073 @default.
- W2805516670 hasConcept C2775934546 @default.
- W2805516670 hasConcept C2777071850 @default.
- W2805516670 hasConcept C2777658100 @default.
- W2805516670 hasConcept C2777744392 @default.
- W2805516670 hasConcept C2779548794 @default.
- W2805516670 hasConcept C502942594 @default.
- W2805516670 hasConcept C71924100 @default.
- W2805516670 hasConceptScore W2805516670C121608353 @default.
- W2805516670 hasConceptScore W2805516670C126322002 @default.
- W2805516670 hasConceptScore W2805516670C126838900 @default.
- W2805516670 hasConceptScore W2805516670C141071460 @default.
- W2805516670 hasConceptScore W2805516670C142724271 @default.
- W2805516670 hasConceptScore W2805516670C16005928 @default.
- W2805516670 hasConceptScore W2805516670C2775842073 @default.
- W2805516670 hasConceptScore W2805516670C2775934546 @default.
- W2805516670 hasConceptScore W2805516670C2777071850 @default.
- W2805516670 hasConceptScore W2805516670C2777658100 @default.
- W2805516670 hasConceptScore W2805516670C2777744392 @default.
- W2805516670 hasConceptScore W2805516670C2779548794 @default.
- W2805516670 hasConceptScore W2805516670C502942594 @default.
- W2805516670 hasConceptScore W2805516670C71924100 @default.
- W2805516670 hasIssue "1" @default.
- W2805516670 hasLocation W28055166701 @default.
- W2805516670 hasLocation W28055166702 @default.
- W2805516670 hasLocation W28055166703 @default.
- W2805516670 hasLocation W28055166704 @default.
- W2805516670 hasOpenAccess W2805516670 @default.
- W2805516670 hasPrimaryLocation W28055166701 @default.
- W2805516670 hasRelatedWork W2021968456 @default.
- W2805516670 hasRelatedWork W2068861579 @default.